Europe Organoids Market is expected to reach US$ 1,260.08 Mn by 2027

Internal Organoids segment is expected to drive the growth of the Europe Organoids market by Technology

According to the latest study on ‘Europe Organoids  Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type, Application, Source, and Country,’ the Europe Organoids market was valued at US$ 247.85 million in 2019 and is projected to reach US$ 1,260.08 million by 2027; it is expected to grow at a CAGR of 22.5% during 2020–2027. The report highlights the trends prevailing in the Europe organoids market and the factors driving the market along with those that act as deterrents to its growth.

Based on type, the organoids market is segmented stomach, intestine, liver, pancreas, lung, brain, kidney, and others. In 2019, the stomach segment accounted for the largest share of the Europe organoids market. The growth of the segment attributes to growth of internal Organoids segment is attributed to the rising stomach disorders are some of the primary factors contributing to the dominance of the segment in the Europe organoids market. Additionally, the outbreak of the COVID-19 pandemic has highly affected the countries in the European region.

STEMCELL Technologies, Inc., Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc.

Organoid Therapeutics, PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life Sciences)

Merck KGgA. are among the prominent players present in the organoids market. The market players are focused on mergers and acquisitions to sustain their position in the market. For instance, in September 2018 STEMCELL Technologies Signs partnership agreement with Brigham and Women’s Hospital to Commercialize Human Pluripotent Stem Cell-Derived Kidney Organoid Culture System.

The report segments the Europe Organoids market as follows:

By Type

• Stomach
• Intestine
• Liver
• Pancreas
• Lung
• Brain
• Kidney
• Others

By Application

• Developmental Biology
• Disease Pathology of Infectious Disease
• Regenerative Medicine
• Drug Toxicity and Efficacy Testing
• Drug Discovery and Personalized Medicine
• Others

By Source

• Pluripotent Stem Cells
• Organ-specific Adult Stem Cells

By Country

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe